WALTHAM, Mass., Oct. 02, 2023 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved the Empaveli® Injector. The Empaveli Injector is a compact, single-use,…Original Article
Apellis Announces U.S. FDA Approval of the Empaveli Injector, a Device to Streamline Self-Administration
